Silencing hepatic PCSK9 via novel chimeric AAV8 mitigates the progression of atherosclerosis by inhibiting inflammation in ApoE−/− mice

Xiaocui Chen(Xinjiang Medical University), Bang‐Dang Chen(Xinjiang Medical University)
Molecular Therapy — Methods & Clinical Development
December 5, 2024
Cited by 7


Related Papers